Skip to main content
Erschienen in: Skeletal Radiology 4/2010

01.04.2010 | Scientific Article

Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma

verfasst von: Andreas Gutzeit, Aleksis Doert, Johannes M. Froehlich, Boris P. Eckhardt, Andreas Meili, Patrick Scherr, Daniel T. Schmid, Nicole Graf, Constantin A. von Weymarn, Edwin M. M. Willemse, Christoph A. Binkert

Erschienen in: Skeletal Radiology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To prospectively compare the diagnostic accuracy of diffusion-weighted whole body imaging with background whole body signal suppression (DWIBS) with skeletal scintigraphy for the diagnosis and differentiation of skeletal lesions in patients suffering from prostate or breast cancer.

Material and Methods

A diagnostic cohort of 36 patients was included in skeletal scintigraphy and 1.5 T DWIBS MRI. Based on morphology and signal intensity patterns, two readers each identified and classified independently, under blinded conditions, all lesions into three groups: (1) malignant, (2) unclear if malignant or benign and (3) benign. Finally, for the definition of the gold standard all available imaging techniques and follow-up over a minimum of 6 months were considered.

Results

Overall, 45 circumscribed bone metastases and 107 benign lesions were found. DWIBS performed significantly better in detecting malignant skeletal lesions in patients with more than 10 lesions (sensitivity: 0.97/0.91) compared to skeletal scintigraphy (sensitivity: 0.48/0.42). No statistical difference could be found between DWIBS (0.58/0.33) and skeletal scintigraphy (0.67/0.58) in the sensitivity values for malignant skeletal lesions in patients with less than 5 lesions. For benign lesions, scintigraphy scored best with a sensitivity of 0.93/0.87 compared to 0.20/0.13 for DWIBS. Interobserver agreement with Cohen’s kappa coefficient was calculated as 0.784 in the case of scintigraphy and 0.663 for DWIBS.

Conclusion

With respect to staging, in prostate and breast carcinoma, the DWIBS technique is not superior to skeletal scintigraphy, but ranks equally. However, in the cases with many bone lesions, markedly more metastases could be discovered using the DWIBS technique than skeletal scintigraphy.
Literatur
1.
Zurück zum Zitat Huisman TA. Diffusion-weighted imaging: basic concepts and application in cerebral stroke and head trauma. Eur Radiol. 2003;13:2283–97.CrossRefPubMed Huisman TA. Diffusion-weighted imaging: basic concepts and application in cerebral stroke and head trauma. Eur Radiol. 2003;13:2283–97.CrossRefPubMed
2.
Zurück zum Zitat Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.CrossRefPubMed Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.CrossRefPubMed
3.
Zurück zum Zitat Mürtz P, Krautmacher C, Träber F, et al. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol. 2007;17:3031–37.CrossRefPubMed Mürtz P, Krautmacher C, Träber F, et al. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol. 2007;17:3031–37.CrossRefPubMed
4.
Zurück zum Zitat Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243–9.CrossRef Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243–9.CrossRef
5.
Zurück zum Zitat Tateishi U, Gamez C, Dawood S, et al. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Radiology. 2008;247:189–96.CrossRefPubMed Tateishi U, Gamez C, Dawood S, et al. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. Radiology. 2008;247:189–96.CrossRefPubMed
6.
Zurück zum Zitat Miller TT. Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology. 2008;246:662–74.CrossRefPubMed Miller TT. Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology. 2008;246:662–74.CrossRefPubMed
7.
Zurück zum Zitat McNeil BJ. Rationale for the use of bone scans in selected metastatic and primary bone tumors. Semin Nucl Med. 1978;8:336–4.CrossRefPubMed McNeil BJ. Rationale for the use of bone scans in selected metastatic and primary bone tumors. Semin Nucl Med. 1978;8:336–4.CrossRefPubMed
8.
Zurück zum Zitat Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci. 2007;6:147–55.CrossRefPubMed Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci. 2007;6:147–55.CrossRefPubMed
9.
Zurück zum Zitat Ghanem N, Altehoefer C, Kelly T, et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo. 2006;20:173–82.PubMed Ghanem N, Altehoefer C, Kelly T, et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo. 2006;20:173–82.PubMed
10.
Zurück zum Zitat Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol. 2002;12:2091–9.PubMed Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol. 2002;12:2091–9.PubMed
11.
Zurück zum Zitat Altehoefer C, Ghanem N, Högerle S, et al. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol. 2001;40(1):16–23.CrossRefPubMed Altehoefer C, Ghanem N, Högerle S, et al. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol. 2001;40(1):16–23.CrossRefPubMed
12.
Zurück zum Zitat Baur A, Stäbler A, Brüning R, et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology. 1998;207:349–56.PubMed Baur A, Stäbler A, Brüning R, et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology. 1998;207:349–56.PubMed
13.
Zurück zum Zitat Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol. 2000;29:555–62.CrossRefPubMed Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol. 2000;29:555–62.CrossRefPubMed
14.
Zurück zum Zitat Moon WJ, Lee MH, Chung EC. Diffusion-weighted imaging with sensitivity encoding (SENSE) for detecting cranial bone marrow metastases: comparison with T1-weighted images. Korean J Radiol. 2007;8:185–91.CrossRefPubMed Moon WJ, Lee MH, Chung EC. Diffusion-weighted imaging with sensitivity encoding (SENSE) for detecting cranial bone marrow metastases: comparison with T1-weighted images. Korean J Radiol. 2007;8:185–91.CrossRefPubMed
15.
Zurück zum Zitat Baur A, Huber A, Ertl-Wagner B, et al. Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR Am J Neuroradiol. 2001;22:366–72.PubMed Baur A, Huber A, Ertl-Wagner B, et al. Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR Am J Neuroradiol. 2001;22:366–72.PubMed
16.
Zurück zum Zitat Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275–82.PubMed Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004;22:275–82.PubMed
17.
Zurück zum Zitat Haubold-Reuter BG, Duewell S, Schilcher BR, et al. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study. Eur J Nucl Med. 1993;20:1063–9.CrossRefPubMed Haubold-Reuter BG, Duewell S, Schilcher BR, et al. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study. Eur J Nucl Med. 1993;20:1063–9.CrossRefPubMed
18.
Zurück zum Zitat Lauenstein TC, Goehde SC, Herborn CU, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol. 2002;179:445–9.PubMed Lauenstein TC, Goehde SC, Herborn CU, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol. 2002;179:445–9.PubMed
19.
Zurück zum Zitat Ketelsen D, Röthke M, Aschoff P et al. Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy] Rofo. 2008 Aug;180(8):746-52. (Epub 2008 May 29) Ketelsen D, Röthke M, Aschoff P et al. Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy] Rofo. 2008 Aug;180(8):746-52. (Epub 2008 May 29)
20.
Zurück zum Zitat Even-Sapir E, Metser U, Mishani E, et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006 Feb;47(2):287–97. Even-Sapir E, Metser U, Mishani E, et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006 Feb;47(2):287–97.
21.
Zurück zum Zitat Tamada T, Nagai K, Iizuka M et al. Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 2000 Apr;60(5):249-54 Tamada T, Nagai K, Iizuka M et al. Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 2000 Apr;60(5):249-54
22.
Zurück zum Zitat Woolfenden JM, Pitt MJ, Durie BG, et al. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology. 1980;134:723–8.PubMed Woolfenden JM, Pitt MJ, Durie BG, et al. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology. 1980;134:723–8.PubMed
23.
Zurück zum Zitat Landgren O, Axdorph U, Jacobsson H, et al. Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin’s disease. Med Oncol. 2000;17:174–8.CrossRefPubMed Landgren O, Axdorph U, Jacobsson H, et al. Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin’s disease. Med Oncol. 2000;17:174–8.CrossRefPubMed
24.
Zurück zum Zitat Baur A, Huber A, Dürr HR, et al. Differentiation of benign osteoporotic and neoplastic vertebral compression fractures with a diffusion-weighted, steady-state free precession sequence. Rofo. 2002;174:70–5.PubMed Baur A, Huber A, Dürr HR, et al. Differentiation of benign osteoporotic and neoplastic vertebral compression fractures with a diffusion-weighted, steady-state free precession sequence. Rofo. 2002;174:70–5.PubMed
25.
Zurück zum Zitat Komori T, Narabayashi I, Matsumura K, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21:209–15.CrossRefPubMed Komori T, Narabayashi I, Matsumura K, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21:209–15.CrossRefPubMed
26.
Zurück zum Zitat Luboldt W, Kuefer R, Blumstein N, et al. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology. 2008;249:1017–25.CrossRefPubMed Luboldt W, Kuefer R, Blumstein N, et al. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology. 2008;249:1017–25.CrossRefPubMed
27.
Zurück zum Zitat Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology. 2008;248:643–54.CrossRefPubMed Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology. 2008;248:643–54.CrossRefPubMed
Metadaten
Titel
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma
verfasst von
Andreas Gutzeit
Aleksis Doert
Johannes M. Froehlich
Boris P. Eckhardt
Andreas Meili
Patrick Scherr
Daniel T. Schmid
Nicole Graf
Constantin A. von Weymarn
Edwin M. M. Willemse
Christoph A. Binkert
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Skeletal Radiology / Ausgabe 4/2010
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-009-0789-4

Weitere Artikel der Ausgabe 4/2010

Skeletal Radiology 4/2010 Zur Ausgabe

Letter to the Editors

Letter to the Editors

Browser's Notes

 

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.